CMC strategy
Development planning, risk framing, phase-appropriate decision support, and program structure.
Executive advisory for biotech programs
Technical and strategic judgment for companies building complex therapeutics.
Eight Crest Strategies advises biologics, cell and gene therapy, and gene editing teams across CMC, technical development, quality systems, and regulatory strategy. The work is designed for executives who need clear priorities, disciplined execution, and technical decisions that support the business as well as the science.
Services
Focused support where technical execution and company priorities need to align.
The advisory model is intentionally lean: direct, senior, and tailored to the real decisions founders and executives need to make.
Technical development
Process and analytical strategy, technology transfer planning, and operational problem-solving.
Quality systems
Quality structures that are credible, practical, and suited to emerging-company realities.
Regulatory positioning
Technical narratives and planning that support filings, agency engagement, and internal alignment.
CRO and CMO management
Oversight, scope review, relationship support, and alignment between vendors and company goals.
Founder and leadership advisory
Senior input on tradeoffs, readiness, investor-facing issues, and critical program choices.
Approach
Measured, discreet, and execution-oriented.
Assess the program
Clarify stage, constraints, operating model, and the specific technical issues that will influence the next milestone.
Define the decision path
Convert complexity into a clear sequence of priorities, owners, and tradeoffs relevant to leadership.
Support execution
Stay engaged enough to keep teams moving while preserving the senior perspective required for executive decision-making.
Eight Crest Strategies is especially well suited to moments when technical decisions carry outsized implications for capital efficiency, external credibility, or development timing. The emphasis is on substance, clarity, and progress.
Contact